Home » Topics » BioWorld Science

BioWorld Science
RSS

Dosing commences in phase II study of STP-705 for keloid scar prevention

July 15, 2021

Escient reports phase I data on EP-547 for pruritus associated with cholestasis and uremia

July 15, 2021

Antibiotics double as antitumor kinase inhibitors

July 15, 2021

Discovery of novel siderophore-monobactam conjugates against P. Aeruginosa

July 15, 2021

Adial reports preclinical data with adenosine analogues for pain

July 15, 2021

CIHR grant supports Arch's evaluation of LSALT in chronic kidney and lung diseases

July 15, 2021

Enrollment begins in phase I study of BI-1810631 in advanced solid tumors

July 15, 2021

DDX21 has prognostic impact in adrenocortical carcinoma

July 15, 2021

Revalesio initiates phase II study of RNS-60 in acute ischemic stroke

July 15, 2021

Qualigen submits IND application for QN-165 for the treatment of COVID-19

July 15, 2021

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026